Chia Stephen相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)

加拿大乳腺癌诊疗指南：HER2+乳腺癌早期和转移期患者系统治疗的国家共识建议（2025年更新）

期刊:Current Oncology

影响因子:3.4

doi:10.3390/curroncol33040200

Kumar, Aalok; Jerzak, Katarzyna J; Gelmon, Karen A; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Joy, Anil Abraham; Laing, Kara; LeVasseur, Nathalie; Sehdev, Sandeep; Simmons, Christine; Webster, Marc; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada

发表日期：2026

文献求助收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025

加拿大乳腺癌诊疗指南：2025年HR+/HER2-转移性乳腺癌患者系统治疗国家共识建议

期刊:Current Oncology

影响因子:3.4

doi:10.3390/curroncol33020106

Jerzak, Katarzyna J; Kumar, Aalok; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Joy, Anil Abraham; Laing, Kara; LeVasseur, Nathalie; Lupichuk, Sasha; Sehdev, Sandeep; Simmons, Christine; Webster, Marc; Gelmon, Karen A; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada

发表日期：2026

文献求助收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025

加拿大乳腺癌诊疗指南：2025年HR+/HER2-早期乳腺癌患者系统治疗国家共识建议

期刊:Current Oncology

影响因子:3.4

doi:10.3390/curroncol33020112

Sehdev, Sandeep; Joy, Anil Abraham; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Gelmon, Karen A; Jerzak, Katarzyna J; Kumar, Aalok; Laing, Kara; LeVasseur, Nathalie; Simmons, Christine; Webster, Marc; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada

发表日期：2026

文献求助收藏

Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer

更正：一项加拿大真实世界、多中心、前瞻性观察性研究，评估了接受内分泌治疗±靶向治疗的HR+HER2阴性晚期乳腺癌患者的治疗持续时间、治疗顺序和总生存期

期刊:Breast Cancer Research and Treatment

doi:10.1007/s10549-026-07934-4

Doyle, Catherine; Lohmann, Ana Elisa; Iqbal, Nayyer; Henning, Jan-Willem; Kulkarni, Swati; Califaretti, Nadia; Hilton, John; Ferrario, Cristiano; Bouganim, Nathaniel; Mates, Mihaela; Guillemette, Stephanie; Leite, Ricardo; Caron, Marc-Andre; Thireau, Francois; Machado, Andres; Chia, Stephen

发表日期：2026

文献求助收藏

Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial

瑞博西尼联合内分泌治疗激素受体阳性/ERBB2阴性早期乳腺癌：NATALEE随机临床试验的4年结果

期刊:Jama Oncology

影响因子:20.1

doi:10.1001/jamaoncol.2025.3700

Fasching, Peter A; Stroyakovskiy, Daniil; Yardley, Denise A; Huang, Chiun-Sheng; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Xu, Binghe; Loi, Sherene; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Hortobagyi, Gabriel N; Slamon, Dennis J; Fresco, Rodrigo; Zarate, Juan Pablo; Li, Zheng; Waters, Sorcha; Hurvitz, Sara A

免疫/内分泌

发表日期：2025

文献求助收藏

Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial

接受瑞博西尼联合非甾体类芳香化酶抑制剂治疗的 HR+/HER2- 早期乳腺癌患者的健康相关生活质量：NATALEE 试验结果

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-24-1724

Fasching, Peter A; Slamon, Dennis; Nowecki, Zbigniew; Kukielka-Budny, Bozena; Stroyakovskiy, Daniil; Yardley, Denise A; Huang, Chiun-Sheng; Chan, Arlene; Chia, Stephen; Martín, Miguel; Rugo, Hope S; Loi, Sherene; Hurvitz, Sara; Untch, Michael; Afenjar, Karen; Fresco, Rodrigo; Danyliv, Andriy; Ferrusi, Ilia; Li, Zheng; Hortobagyi, Gabriel

发表日期：2025

文献求助收藏

Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancer

对芳香化酶抑制剂与他莫昔芬治疗HR+/HER2-早期乳腺癌患者的系统性文献综述和试验水平荟萃分析

影响因子:7.9

doi:10.1016/j.breast.2025.104429

Janni, Wolfgang; Untch, Michael; Harbeck, Nadia; Gligorov, Joseph; Jacot, William; Chia, Stephen; Boileau, Jean-François; Gupta, Subhajit; Mishra, Namita; Akdere, Murat; Danyliv, Andriy; Curigliano, Giuseppe

发表日期：2025

文献求助收藏

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

在随机 RxPONDER 试验中，种族与激素受体阳性、HER2 阴性、淋巴结阳性乳腺癌患者的临床结局之间的关系

期刊:Jnci-Journal of the National Cancer Institute

影响因子:7.2

doi:10.1093/jnci/djae314

Abdou, Yara; Barlow, William E; Gralow, Julie R; Meric-Bernstam, Funda; Albain, Kathy S; Hayes, Daniel F; Lin, Nancy U; Perez, Edith A; Goldstein, Lori J; Chia, Stephen K L; Dhesy-Thind, Sukhbinder; Rastogi, Priya; Alba, Emilio; Delaloge, Suzette; Schott, Anne F; Shak, Steven; Sharma, Priyanka; Lew, Danika L; Miao, Jieling; Unger, Joseph M; Tripathy, Debasish; Hortobagyi, Gabriel N; Pusztai, Lajos; Kalinsky, Kevin

免疫/内分泌

发表日期：2025

文献求助收藏

Clinician's guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer

临床医生指南：专家对早期乳腺癌患者使用 CDK4/6 抑制剂的见解

期刊:Therapeutic Advances in Medical Oncology

影响因子:4.2

doi:10.1177/17588359251326710

Hussain, Marya; Brezden-Masley, Christine; Chia, Stephen; Curigliano, Giuseppe; Webster, Marc; Henning, Jan-Willem

发表日期：2025

文献求助收藏

Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors

克隆性造血功能不明及其与实体瘤患者治疗结果和不良事件的关系

期刊:Cancer Research Communications

影响因子:3.3

doi:10.1158/2767-9764.CRC-24-0522

Krishnan, Tharani; Solar Vasconcelos, Joao Paulo; Titmuss, Emma; Vanner, Robert J; Schaeffer, David F; Karsan, Aly; Lim, Howard; Ho, Cheryl; Gill, Sharlene; Yip, Stephen; Chia, Stephen K; Kennecke, Hagen F; Jonker, Derek J; Chen, Eric X; Renouf, Daniel J; O'Callaghan, Chris J; Loree, Jonathan M

发表日期：2025

文献求助收藏